Forgot Password.
By Logging in, you are agreeing to the MedSearch Global Terms of Use and Privacy Policy.
Not a member? Sign Up
By Signing up, you are agreeing to the MedSearch Global Terms of Use and Privacy Policy.
Have an account? Log in
Back to Login? Log in
By registering in, you are agreeing to the MedSearch Global terms and condition and Privacy Policy.
Thinking of joining a study?
Register your interest
7243 results
Interventional
Early_phase1
8
Darzalex Faspro (Daratumumab and Hyaluronidase-Fihj)
JH-DSA Semi-Quant Screen and Response Score
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Source: clinicaltrials.gov
Phase1
40
[68Ga]Ga DOTA-5G and [177Lu]Lu DOTA-ABM-5G.
University of California, Davis
Phase3
402
Darolutamide (Nubeka, Bay1841788)
Bayer
Phase2
136
NGH120 Q4W
NGM120 Q8W
Placebo given
NGM Biopharmaceuticals, Inc
Observational
Not Applicable
5000
Vanderbilt University Medical Center
18
CD30.CAR-EBVST cells
Baylor College of Medicine
483
Then-robot
TRUS biopsy
Johns Hopkins University
30
photochemotherapy using 3-(1-Butyloxy)ethyl-3-deacetyl-bacteriopurpurin-18-n-butylimide methyl ester(Photobac®)
Photolitec LLC
70
Cyclophosphamide
Fludarabine
Aldesleukin
Act-turies gus 12 petccations
National Cancer Institute (NCI)
60
Yoga Sessions
Questionnaries
Interviews
M.D. Anderson Cancer Center